References
- Droder RM, Kyle RA, Greipp PR. Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med 1992;92:523–6.
- McCann S, Akilov OE, Geskin L. Adverse effects of denileukin diftitox and their management in patients with cutaneous T-cell lymphoma. Clin J Oncol Nurs 2012;16:164–72.
- Dagdemir A, Albayrak D, Dilber C, Totan M. G-CSF related capillary leak syndrome in a child with leukemia. Leuk Lymphoma 2001;42:1445–7.
- Hsiao S-C, Wang M-C, Chang H, Pei S-N. Recurrent capillary leak syndrome following bortezomib therapy in a patient with relapsed myeloma. Ann Pharmacother 2010;44:587–9.
- Guffroy A, Dervieux B, Gravier S, Martinez C, Deibener-Kaminsky J, Hachulla E, et al. Club des Rhumatismes et Inflammations (CRI). Systemic capillary leak syndrome and autoimmune diseases: a case series. Semin Arthritis Rheum 2017;46:509–12.
- Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro(SSA) anti-bodies. J Invest Dermatol 1983;80:386–91.
- Marra AM, Gigante A, Rosato E. Intravenous immunoglobulin in systemic capillary leak syndrome: a case report and review of literature. Expert Rev Clin Immunol 2014;10:349–52.
- Mullane R, Langewisch E, Florescu M, Plumb T. Chronic systemic capillary leak syndrome treatment with intravenous immune globulin: case report and review of the literature. Clin Nephrol 2019;91:59–63.
- Matucci A, Maggi E, Vultaggio A. Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects. Front Immunol 2015;5:690.
- Xie Z, Chan EC, Long LM, Nelson C, Druey KM. High-dose intravenous immunoglobulin therapy for systemic capillary leak syndrome (Clarkson disease). Am J Med 2015;128:91–5.